Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Standardizing Prurigo Control Assessment Globally: Linguistic Validation and Cross-cultural Adaptation of Prurigo Control Test in 18 Languages.

Acta dermato-venereologica·2026
Same author

A Real-World Cross-Sectional Study on Suspected Mast Cell Activation Syndrome: Multiple Heterogeneous Symptoms Identified.

Clinical and translational allergy·2026
Same author

Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry study.

Journal of hematology & oncology·2026
Same author

Psychometric evaluation of the Mastocytosis Symptom Severity Daily Diary (MS2D2) in adults with nonadvanced systemic mastocytosis (NonAdvSM).

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2026
Same author

Reply to "Chronic Spontaneous Urticaria: The Most Common MCAS-Like Disease".

The journal of allergy and clinical immunology. In practice·2026
Same author

Differential susceptibility of hair colour changes after barzolvolimab.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Related Experiment Video

Updated: Jun 5, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.2K

The Mastocytosis Control Test: A Patient-Reported Outcome Measure Assessing Disease Control.

Frank Siebenhaar1, Senan Sofi1, Sophia Neisinger1

  • 1Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Insititute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.

The Journal of Allergy and Clinical Immunology. in Practice
|December 5, 2024
PubMed
Summary
This summary is machine-generated.

A new Mastocytosis Control Test (MCT) effectively measures disease control in nonadvanced mastocytosis patients. This validated patient-reported outcome measure (PROM) aids in monitoring symptoms and treatment efficacy in clinical practice.

Keywords:
Control testImpact analysisMastocytosisQuality of lifeSymptoms

More Related Videos

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.3K
High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids
06:25

High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids

Published on: June 14, 2021

5.2K

Related Experiment Videos

Last Updated: Jun 5, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.2K
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.3K
High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids
06:25

High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids

Published on: June 14, 2021

5.2K

Area of Science:

  • Hematology
  • Oncology
  • Patient-Reported Outcomes

Background:

  • Mastocytosis involves neoplastic mast cell expansion in organs, leading to various symptoms.
  • Currently, a validated patient-reported outcome measure (PROM) for mastocytosis disease control is lacking.

Purpose of the Study:

  • To develop and validate the Mastocytosis Control Test (MCT) for assessing disease control in nonadvanced mastocytosis.

Main Methods:

  • Generated potential items through literature review, patient interviews, and expert input.
  • Reduced and selected items using impact analysis, interitem correlation, expert reviews, and cognitive debriefings.
  • Validated the MCT for internal consistency, test-retest reliability, convergent validity, known-groups validity, and ROC analysis.

Main Results:

  • The final 5-item MCT demonstrated a valid total score with high internal consistency and test-retest reliability.
  • Convergent and known-groups validity showed strong correlations with related measures.
  • ROC analysis indicated a cutoff of ≥13 points for good disease control.

Conclusions:

  • The MCT is a disease-specific, valid, and reliable PROM for adult patients with nonadvanced mastocytosis.
  • The MCT can be utilized for measuring and monitoring disease control in routine care and clinical trials.